ReposiTrak (TRAK)vsZepp Health Corp (ZEPP)
TRAK
ReposiTrak
$9.94
+1.64%
TECHNOLOGY · Cap: $162.92M
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Zepp Health Corp generates 1002% more annual revenue ($258.90M vs $23.50M). TRAK leads profitability with a 30.9% profit margin vs -15.5%. TRAK earns a higher WallStSmart Score of 62/100 (C+).
TRAK
Buy62
out of 100
Grade: C+
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-72.6%
Fair Value
$5.98
Current Price
$9.94
$3.96 premium
Margin of Safety
+48.8%
Fair Value
$46.82
Current Price
$17.47
$29.35 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Keeps 31 of every $100 in revenue as profit
Strong operational efficiency at 31.0%
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Growing faster than its price suggests
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
Smaller company, higher risk/reward
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : TRAK
The strongest argument for TRAK centers on Profit Margin, Operating Margin, Debt/Equity. Profitability is solid with margins at 30.9% and operating margin at 31.0%. PEG of 0.74 suggests the stock is reasonably priced for its growth.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : TRAK
The primary concerns for TRAK are Market Cap.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
TRAK profiles as a mature stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
TRAK scores higher overall (62/100 vs 41/100), backed by strong 30.9% margins. ZEPP offers better value entry with a 48.8% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
ReposiTrak
TECHNOLOGY · SOFTWARE - APPLICATION · USA
ReposiTrak, Inc. (Ticker: TRAK) is a premier provider of supply chain management solutions, focusing on risk management and compliance across the retail and foodservice industries. By harnessing advanced technology, the company offers real-time insights that not only enhance operational efficiency but also ensure adherence to regulatory standards. With a robust supplier network and a strong commitment to innovation, ReposiTrak acts as a strategic partner for organizations seeking to fortify their supply chain integrity. Positioned for continuous growth, the company aims to deliver value to its stakeholders by promoting safer and more efficient consumer goods transactions.
Visit Website →Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SOFTWARE - APPLICATION Stocks
Want to dig deeper into these stocks?